Dr. Cantu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-648-0921Fax+1 214-648-0952- Is this information wrong?
Summary
- Dr. Miguel Cantu is a pathologist in Dallas, TX and is affiliated with the a University of Texas Southwestern. He received his medical degree from McGovern Medical School. He completed residency in Anatomic and Clinical Pathology and Hematopathology fellowship at New York Presbyterian-Weill Cornell and Molecular Genetic Pathology fellowship at UTSW.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Molecular Genetic Pathology, 2021 - 2022
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematopathology, 2020 - 2021- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2016 - 2020
McGovern Medical School at UTHealthClass of 2016
Certifications & Licensure
TX State Medical License 2022 - 2025
NY State Medical License 2020 - 2022- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematology
- American Board of Pathology Molecular Genetic Pathology
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype.Koduru, P., Collins, R., Chung, S., Zheng, R., Fuda, F., Gagan, J., Weinberg, O., Cantu, M., Ludwig, K., Truscott, J., Madanat, Y., Chen, W.> ;Leukemia Research Reports. 2024 Jan 1
- Pancytopenia and haematopoietic precursor vacuolisation in an infant: Clues to Pearson syndrome.Jordan H Driskill, Miguel Dario Cantu, Jessica Garcia, Kathryn E Dickerson, Weina Chen> ;British Journal of Haematology. 2023 Sep 1
- Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities.Olga K Weinberg, Miguel D Cantu, Jeffrey Gagan, Yazan F Madanat, Daniel A Arber, Robert P Hasserjian> ;Ejhaem. 2023 Aug 1
- Join now to see all
Hospital Affiliations
University of Texas Southwestern Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
